Table 1 Cohort characteristics
Frequency (%) | |
|---|---|
Patients | 259 (100) |
Pathologic tumor stage | |
pT1a | 7 (2.7) |
pT2a | 26 (10.0) |
pT2b | 5 (1.9) |
pT2c | 132 (51.0) |
pT3a | 52 (20.1) |
pT3b | 36 (13.9) |
ypT4 | 1 (0.4) |
Lymph node status | |
pNx | 1 (0.4) |
pN0 | 237 (91.5) |
pN1 | 21 (8.1) |
Surgical margin status | |
Rx | 2 (0.8) |
R0 | 197 (76.1) |
R1 | 60 (23.2) |
Lymph vessel involvement | |
Lx | 1 (0.4) |
L0 | 188 (72.6) |
L1 | 70 (27.0) |
Vein involvement | |
Vx | 1 (0.4) |
V0 | 235 (90.7) |
V1 | 23 (8.9) |
Gleason Score | |
5 | 5 (1.9) |
6 | 53 (20.5) |
7 | 151 (58.3) |
8 | 5 (1.9) |
9 | 43 (16.6) |
Cannot be estimated | 2 (0.8) |
HELPAP | |
Ib | 4 (1.5) |
IIa | 78 (30.1) |
IIb | 96 (37.1) |
IIIa | 26 (10.0) |
IIIb | 53 (20.5) |
Cannot be estimated | 2 (0.8) |